Searched for
GLP 1 MEDICATION
Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- As weight-loss drug users turn to dietary supplements, doctors, regulators raise flagsThe growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to...
- GLP-1 prices drop at Mochi Health, starting at $60 but what will patients actually pay?Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...
- GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports revealinsulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...
- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Earth’s 7 of 9 Planetary Boundaries have been breached: Amazon, oceans and climate are among systems under pressure as situations continue to worsenEarth's natural systems face mounting pressures, with seven of nine planetary boundaries now breached. The Planetary Health Check 2026 high...
- 2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stagePredictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...
- Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- Protein boom sparks deals, partnerships across F&B spaceConsumer demand for protein in everyday staples is driving new product launches and supply deals. Food and beverage makers and cafe chains ...
- Growing peptide trend raises safety concerns among doctorsDoctors express concern over popular injectable peptides for various health benefits. They caution that established peptide medicines diffe...
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilitiesRPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...
- In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
Load More
